Fibrin‐based haemostatic agents vs placebo or no intervention
Serious adverse events Median · adults undergoing liver resection for cancer or benign disease
It is very uncertain whether fibrin‐based haemostatic agents changes serious adverse events Median compared with no intervention or placebo (very low certainty).
1 finding from 1 review
- Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection 2023 · Cochrane Headline outcomes onlyRR 0.96 [0.88, 1.05]4 studies · 782 participantsVery low